Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.75 -6.36% 25.75 25.50 26.00 27.25 25.50 27.25 1,170,888 15:26:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.2 -4.5 - 53

Futura Medical Share Discussion Threads

Showing 17026 to 17047 of 17700 messages
Chat Pages: Latest  684  683  682  681  680  679  678  677  676  675  674  673  Older
DateSubjectAuthorDiscuss
17/7/2019
07:48
I guess Zak Mir is looking at the energy of the rise in august 2016 when the shares moved from 20p to 90p in around one month. This time around we are 3 months away from phase 3 trials results. Charts are not gospel but can provide useful information about likely moves. 2016 was likely a dress rehearsal,now comes the main event.
j777j
17/7/2019
04:26
I was actually thinking leaks of a different type....good one though
tommyl1
17/7/2019
03:58
Ahh, you've heard about the incontinence side effect then.
glavey
16/7/2019
19:42
Great couple of days. Maybe some leaks from study participants as to how well it works? That would be nice.
tommyl1
16/7/2019
18:54
Well, he's a chartist, so to be taken with a pinch of salt. But many would have bought here because, effectively, it is going up, and 'every share price tells a story'. It should not be the only factor, clearly.
brucie5
16/7/2019
18:52
Everyone has some capability, influence and credibility - its just a matter of how much :-)
ragnarr
16/7/2019
17:46
I'm not being funny, but Zak Mir has no investment capability, influence or credibility. he's been unsuccessfully self promoting for over 20 years. don't think he has any insight, because he doesn't !
bg23
16/7/2019
16:36
I was buying these in the Spring when I was chilling in Morocco around 15p from memory, see no reason to sell, holding for 2-5 yrs.
ny boy
16/7/2019
16:19
Does look very strong buying, each time it gets sold down, up it goes again. Let's see what unfolds, but last 3 weeks right angled increase and doubling of share price suggests something worthwhile IMO! DYOR
qs99
16/7/2019
16:18
big buyer moping all these sells looks like stake building for take over
goldie40
16/7/2019
15:05
Zak Mir has just upped one month target for futura to 80p. GLA
j777j
16/7/2019
14:18
Perhaps the chart will let me knowLombards next move. Now that would be something!
wantage
16/7/2019
13:40
You like FUM ? Then you will love Diurnal Group (DNL.L) a brutally undervalued & undiscovered gem . Diurnal has a ridiculous low valuation of only £24 Million and over £11 million in cash , the company has already one Drug (Alkindi)approved in europe since last year ,NDA submission for US approval expected next quarter . They have another Drug called Chronocort for which they expect to submit the MAA to EMA for European approval by next quarter .Get some and enjoy the ride to 100p++ very soon thank me later Diurnal Group (DNL.L) Market Cap £25 Million Cash £11.5 Million Price 27p hxxps://www.diurnal.co.uk/non-healthcare-professionals/media/news/placing-open-offer-and-notice-of-general-meeting/ oFiling a Market Authorisation Application (MAA) for Chronocort® in Europe by end 2019; oFiling a New Drug Application (NDA) for Alkindi® in the US by end 2019; oContinuing the development of the European commercial organisation and roll-out of Alkindi® in Europe to maximise revenues; and oProgressing licensing discussions for Alkindi® and Chronocort® in the US and the rest of the world Martin Whitaker, PhD, Chief Executive Officer of Diurnal, commented: “Diurnal has continued to make strong progress across its business, including the successful launch of Alkindi® in Europe and confirmation of the regulatory paths for Chronocort® in Europe and Alkindi® in the US, where regulatory submissions are planned for Q4 2019. The funds raised will allow us to progress our vision of becoming a world-leading specialty pharma company in endocrinology, in particular to support the commercial infrastructure for the further roll-out of Alkindi® in Europe, paving the way for the expected future launch of Chronocort®, and to secure partnerships for Alkindi® and Chronocort® outside of Europe.”
ih_116147
16/7/2019
13:06
According to Zak Mir at Share Talk FUM is set to hit 80p in the next month or two hxxps://www.share-talk.com/share-talk-bulletin-board-heroes-tuesday-16th-july-2019/
guessing
16/7/2019
12:15
60p next resistance.
j777j
16/7/2019
12:09
Lombard Odier selling into strengthAs they always do when there's enough buying interest.in this case we are hostages to fortune.No disclosures on buy side, wonder if Liberum has got institutions nibbling.Would be wonderful to see someone Buying chunk of L O's stake if they'd Let it go.I'm waiting for next rns announcingAnother million share reduction, and price coming back a few pence.50p hard to crack.
wantage
16/7/2019
11:52
If you take a very conservative look at the numbers,Liberum's 140p is in my opinion a low end valuation range of 140p/250p if trials are passed with flying colours.
j777j
16/7/2019
11:27
It's up in 5 -10minutes......but how long does it stay up?Some women can be very demanding
kop202
16/7/2019
11:15
The question must be whether any potential licensee decides it is better to conclude a deal at these levels? If not, pay possibly vast amounts more,in a bidding war with other players. The product is first major ED breakthrough in 20 years. Is applied topically Works within 5 to 10 mins v up to one hour for Viagra,Cialis etc. Please form an orderly queue.
j777j
16/7/2019
10:59
But why wait till Sept/Dec when the writing is on the wall now about the potential
tiananmen
16/7/2019
10:52
Assuming regulatory approval for both MED2005 and TPR100 (the odds of which are getting ever more short) this will be in the pounds not pence, however I cant find an explanation for the last few days rise. MED2005 is well off until end of year (earliest end Oct, probably later) and nothing is expected from Thornton & Ross on TPR100 Until Sept earliest. So there is something else out there – Good obviously...but what?
ragnarr
16/7/2019
10:04
135k gone through. Someone is confident!
ch4p_85
Chat Pages: Latest  684  683  682  681  680  679  678  677  676  675  674  673  Older
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191024 01:47:36